nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—kidney cancer—liver cancer	0.259	0.509	CtDrD
Paclitaxel—lung cancer—liver cancer	0.25	0.491	CtDrD
Paclitaxel—ABCC10—Doxorubicin—liver cancer	0.0407	0.159	CbGbCtD
Paclitaxel—ABCC1—Epirubicin—liver cancer	0.0296	0.116	CbGbCtD
Paclitaxel—ABCB11—Doxorubicin—liver cancer	0.0221	0.0864	CbGbCtD
Paclitaxel—CYP1B1—Doxorubicin—liver cancer	0.0221	0.0864	CbGbCtD
Paclitaxel—ABCC2—Sorafenib—liver cancer	0.0192	0.0749	CbGbCtD
Paclitaxel—ABCB11—bile canaliculus—liver cancer	0.0178	0.353	CbGeAlD
Paclitaxel—ABCG2—Sorafenib—liver cancer	0.0173	0.0677	CbGbCtD
Paclitaxel—ABCC1—Doxorubicin—liver cancer	0.0157	0.0614	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0128	0.05	CbGbCtD
Paclitaxel—CYP3A7—Sorafenib—liver cancer	0.0128	0.05	CbGbCtD
Paclitaxel—ABCC2—Doxorubicin—liver cancer	0.0116	0.0454	CbGbCtD
Paclitaxel—ABCG2—Doxorubicin—liver cancer	0.0105	0.0411	CbGbCtD
Paclitaxel—CYP3A5—Sorafenib—liver cancer	0.0096	0.0375	CbGbCtD
Paclitaxel—CYP2C8—Sorafenib—liver cancer	0.00923	0.0361	CbGbCtD
Paclitaxel—ABCC2—bile canaliculus—liver cancer	0.00906	0.18	CbGeAlD
Paclitaxel—CYP2C9—Sorafenib—liver cancer	0.00644	0.0252	CbGbCtD
Paclitaxel—ABCB1—Sorafenib—liver cancer	0.00625	0.0244	CbGbCtD
Paclitaxel—ABCB11—bile duct—liver cancer	0.00557	0.11	CbGeAlD
Paclitaxel—ABCB11—bile—liver cancer	0.00428	0.0848	CbGeAlD
Paclitaxel—ABCB1—Doxorubicin—liver cancer	0.00379	0.0148	CbGbCtD
Paclitaxel—CYP3A4—Sorafenib—liver cancer	0.00374	0.0146	CbGbCtD
Paclitaxel—ABCC2—bile duct—liver cancer	0.00283	0.0561	CbGeAlD
Paclitaxel—CYP3A4—Doxorubicin—liver cancer	0.00227	0.00888	CbGbCtD
Paclitaxel—ABCC2—bile—liver cancer	0.00218	0.0431	CbGeAlD
Paclitaxel—MAP4—embryo—liver cancer	0.000997	0.0198	CbGeAlD
Paclitaxel—MAP2—embryo—liver cancer	0.000785	0.0156	CbGeAlD
Paclitaxel—NR1I2—liver—liver cancer	0.000705	0.014	CbGeAlD
Paclitaxel—TUBB4A—embryo—liver cancer	0.000607	0.012	CbGeAlD
Paclitaxel—TUBB4B—embryo—liver cancer	0.000473	0.00938	CbGeAlD
Paclitaxel—MAP4—liver—liver cancer	0.000461	0.00914	CbGeAlD
Paclitaxel—SLCO1B3—liver—liver cancer	0.000404	0.008	CbGeAlD
Paclitaxel—MAP2—liver—liver cancer	0.000363	0.0072	CbGeAlD
Paclitaxel—ABCB11—liver—liver cancer	0.000348	0.0069	CbGeAlD
Paclitaxel—CYP3A7—liver—liver cancer	0.000341	0.00675	CbGeAlD
Paclitaxel—CYP3A7-CYP3A51P—liver—liver cancer	0.00029	0.00574	CbGeAlD
Paclitaxel—TUBB4A—liver—liver cancer	0.000281	0.00556	CbGeAlD
Paclitaxel—TUBB—liver—liver cancer	0.000257	0.00509	CbGeAlD
Paclitaxel—TUBB2A—liver—liver cancer	0.000255	0.00506	CbGeAlD
Paclitaxel—TUBB6—liver—liver cancer	0.000252	0.00499	CbGeAlD
Paclitaxel—ABCC10—liver—liver cancer	0.000221	0.00437	CbGeAlD
Paclitaxel—TUBB4B—liver—liver cancer	0.000219	0.00434	CbGeAlD
Paclitaxel—CYP19A1—liver—liver cancer	0.000185	0.00367	CbGeAlD
Paclitaxel—ABCC2—liver—liver cancer	0.000177	0.00351	CbGeAlD
Paclitaxel—CYP1B1—liver—liver cancer	0.000173	0.00344	CbGeAlD
Paclitaxel—ABCC1—liver—liver cancer	0.000156	0.00309	CbGeAlD
Paclitaxel—ABCB1—embryo—liver cancer	0.000138	0.00273	CbGeAlD
Paclitaxel—CYP2C8—liver—liver cancer	0.000133	0.00263	CbGeAlD
Paclitaxel—ABCG2—liver—liver cancer	0.000129	0.00256	CbGeAlD
Paclitaxel—CYP3A5—liver—liver cancer	0.00012	0.00237	CbGeAlD
Paclitaxel—CYP2C9—liver—liver cancer	0.000118	0.00234	CbGeAlD
Paclitaxel—CYP3A4—liver—liver cancer	8.99e-05	0.00178	CbGeAlD
Paclitaxel—Ataxia—Doxorubicin—liver cancer	6.52e-05	0.000633	CcSEcCtD
Paclitaxel—Blood creatinine increased—Doxorubicin—liver cancer	6.5e-05	0.00063	CcSEcCtD
Paclitaxel—Influenza—Epirubicin—liver cancer	6.48e-05	0.000628	CcSEcCtD
Paclitaxel—Dysphagia—Epirubicin—liver cancer	6.48e-05	0.000628	CcSEcCtD
Paclitaxel—Dehydration—Doxorubicin—liver cancer	6.45e-05	0.000626	CcSEcCtD
Paclitaxel—Liver function test abnormal—Doxorubicin—liver cancer	6.41e-05	0.000621	CcSEcCtD
Paclitaxel—ABCB1—liver—liver cancer	6.37e-05	0.00126	CbGeAlD
Paclitaxel—Dry skin—Doxorubicin—liver cancer	6.36e-05	0.000617	CcSEcCtD
Paclitaxel—Pancreatitis—Epirubicin—liver cancer	6.35e-05	0.000616	CcSEcCtD
Paclitaxel—Vomiting—Sorafenib—liver cancer	6.34e-05	0.000615	CcSEcCtD
Paclitaxel—Abdominal pain upper—Doxorubicin—liver cancer	6.34e-05	0.000614	CcSEcCtD
Paclitaxel—Orthostatic hypotension—Doxorubicin—liver cancer	6.34e-05	0.000614	CcSEcCtD
Paclitaxel—Hypokalaemia—Doxorubicin—liver cancer	6.32e-05	0.000612	CcSEcCtD
Paclitaxel—Rash—Sorafenib—liver cancer	6.29e-05	0.00061	CcSEcCtD
Paclitaxel—Dermatitis—Sorafenib—liver cancer	6.28e-05	0.000609	CcSEcCtD
Paclitaxel—Breast disorder—Doxorubicin—liver cancer	6.27e-05	0.000608	CcSEcCtD
Paclitaxel—Aspartate aminotransferase increased—Doxorubicin—liver cancer	6.25e-05	0.000606	CcSEcCtD
Paclitaxel—Toxic epidermal necrolysis—Doxorubicin—liver cancer	6.25e-05	0.000606	CcSEcCtD
Paclitaxel—Headache—Sorafenib—liver cancer	6.25e-05	0.000606	CcSEcCtD
Paclitaxel—Bronchitis—Epirubicin—liver cancer	6.23e-05	0.000604	CcSEcCtD
Paclitaxel—Nasopharyngitis—Doxorubicin—liver cancer	6.21e-05	0.000602	CcSEcCtD
Paclitaxel—Pancytopenia—Epirubicin—liver cancer	6.16e-05	0.000597	CcSEcCtD
Paclitaxel—Alanine aminotransferase increased—Doxorubicin—liver cancer	6.12e-05	0.000593	CcSEcCtD
Paclitaxel—Muscular weakness—Doxorubicin—liver cancer	6.12e-05	0.000593	CcSEcCtD
Paclitaxel—Dysuria—Epirubicin—liver cancer	6.06e-05	0.000588	CcSEcCtD
Paclitaxel—Neutropenia—Epirubicin—liver cancer	6.06e-05	0.000588	CcSEcCtD
Paclitaxel—Abdominal distension—Doxorubicin—liver cancer	6.04e-05	0.000585	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Epirubicin—liver cancer	6.02e-05	0.000584	CcSEcCtD
Paclitaxel—Influenza—Doxorubicin—liver cancer	6e-05	0.000581	CcSEcCtD
Paclitaxel—Dysphagia—Doxorubicin—liver cancer	6e-05	0.000581	CcSEcCtD
Paclitaxel—Pollakiuria—Epirubicin—liver cancer	5.99e-05	0.00058	CcSEcCtD
Paclitaxel—Nausea—Sorafenib—liver cancer	5.92e-05	0.000574	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Epirubicin—liver cancer	5.92e-05	0.000574	CcSEcCtD
Paclitaxel—Weight increased—Epirubicin—liver cancer	5.9e-05	0.000572	CcSEcCtD
Paclitaxel—Pancreatitis—Doxorubicin—liver cancer	5.88e-05	0.00057	CcSEcCtD
Paclitaxel—Weight decreased—Epirubicin—liver cancer	5.86e-05	0.000569	CcSEcCtD
Paclitaxel—Hyperglycaemia—Epirubicin—liver cancer	5.85e-05	0.000567	CcSEcCtD
Paclitaxel—Pneumonia—Epirubicin—liver cancer	5.81e-05	0.000564	CcSEcCtD
Paclitaxel—Infestation NOS—Epirubicin—liver cancer	5.78e-05	0.00056	CcSEcCtD
Paclitaxel—Infestation—Epirubicin—liver cancer	5.78e-05	0.00056	CcSEcCtD
Paclitaxel—Bronchitis—Doxorubicin—liver cancer	5.77e-05	0.000559	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Epirubicin—liver cancer	5.73e-05	0.000555	CcSEcCtD
Paclitaxel—Pancytopenia—Doxorubicin—liver cancer	5.7e-05	0.000552	CcSEcCtD
Paclitaxel—Renal failure—Epirubicin—liver cancer	5.68e-05	0.000551	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Epirubicin—liver cancer	5.67e-05	0.000549	CcSEcCtD
Paclitaxel—Stomatitis—Epirubicin—liver cancer	5.63e-05	0.000546	CcSEcCtD
Paclitaxel—Urinary tract infection—Epirubicin—liver cancer	5.62e-05	0.000545	CcSEcCtD
Paclitaxel—Conjunctivitis—Epirubicin—liver cancer	5.62e-05	0.000545	CcSEcCtD
Paclitaxel—Dysuria—Doxorubicin—liver cancer	5.61e-05	0.000544	CcSEcCtD
Paclitaxel—Neutropenia—Doxorubicin—liver cancer	5.61e-05	0.000544	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Doxorubicin—liver cancer	5.57e-05	0.00054	CcSEcCtD
Paclitaxel—Pollakiuria—Doxorubicin—liver cancer	5.54e-05	0.000537	CcSEcCtD
Paclitaxel—Haematuria—Epirubicin—liver cancer	5.51e-05	0.000534	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Doxorubicin—liver cancer	5.47e-05	0.000531	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Epirubicin—liver cancer	5.47e-05	0.00053	CcSEcCtD
Paclitaxel—Weight increased—Doxorubicin—liver cancer	5.46e-05	0.000529	CcSEcCtD
Paclitaxel—Epistaxis—Epirubicin—liver cancer	5.45e-05	0.000528	CcSEcCtD
Paclitaxel—Weight decreased—Doxorubicin—liver cancer	5.43e-05	0.000526	CcSEcCtD
Paclitaxel—Sinusitis—Epirubicin—liver cancer	5.42e-05	0.000526	CcSEcCtD
Paclitaxel—Hyperglycaemia—Doxorubicin—liver cancer	5.41e-05	0.000524	CcSEcCtD
Paclitaxel—Pneumonia—Doxorubicin—liver cancer	5.38e-05	0.000521	CcSEcCtD
Paclitaxel—Infestation NOS—Doxorubicin—liver cancer	5.35e-05	0.000518	CcSEcCtD
Paclitaxel—Infestation—Doxorubicin—liver cancer	5.35e-05	0.000518	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Doxorubicin—liver cancer	5.3e-05	0.000514	CcSEcCtD
Paclitaxel—Bradycardia—Epirubicin—liver cancer	5.28e-05	0.000512	CcSEcCtD
Paclitaxel—Renal failure—Doxorubicin—liver cancer	5.26e-05	0.00051	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Doxorubicin—liver cancer	5.24e-05	0.000508	CcSEcCtD
Paclitaxel—Haemoglobin—Epirubicin—liver cancer	5.21e-05	0.000506	CcSEcCtD
Paclitaxel—Stomatitis—Doxorubicin—liver cancer	5.21e-05	0.000505	CcSEcCtD
Paclitaxel—Rhinitis—Epirubicin—liver cancer	5.2e-05	0.000504	CcSEcCtD
Paclitaxel—Urinary tract infection—Doxorubicin—liver cancer	5.2e-05	0.000504	CcSEcCtD
Paclitaxel—Conjunctivitis—Doxorubicin—liver cancer	5.2e-05	0.000504	CcSEcCtD
Paclitaxel—Haemorrhage—Epirubicin—liver cancer	5.19e-05	0.000503	CcSEcCtD
Paclitaxel—Hypoaesthesia—Epirubicin—liver cancer	5.16e-05	0.0005	CcSEcCtD
Paclitaxel—Pharyngitis—Epirubicin—liver cancer	5.15e-05	0.000499	CcSEcCtD
Paclitaxel—Urinary tract disorder—Epirubicin—liver cancer	5.12e-05	0.000497	CcSEcCtD
Paclitaxel—Oedema peripheral—Epirubicin—liver cancer	5.11e-05	0.000495	CcSEcCtD
Paclitaxel—Haematuria—Doxorubicin—liver cancer	5.1e-05	0.000494	CcSEcCtD
Paclitaxel—Connective tissue disorder—Epirubicin—liver cancer	5.1e-05	0.000494	CcSEcCtD
Paclitaxel—Urethral disorder—Epirubicin—liver cancer	5.09e-05	0.000493	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Doxorubicin—liver cancer	5.06e-05	0.00049	CcSEcCtD
Paclitaxel—Epistaxis—Doxorubicin—liver cancer	5.04e-05	0.000489	CcSEcCtD
Paclitaxel—Sinusitis—Doxorubicin—liver cancer	5.02e-05	0.000486	CcSEcCtD
Paclitaxel—Visual impairment—Epirubicin—liver cancer	5e-05	0.000485	CcSEcCtD
Paclitaxel—Erythema multiforme—Epirubicin—liver cancer	4.91e-05	0.000476	CcSEcCtD
Paclitaxel—Bradycardia—Doxorubicin—liver cancer	4.89e-05	0.000474	CcSEcCtD
Paclitaxel—Eye disorder—Epirubicin—liver cancer	4.85e-05	0.00047	CcSEcCtD
Paclitaxel—Tinnitus—Epirubicin—liver cancer	4.84e-05	0.000469	CcSEcCtD
Paclitaxel—Haemoglobin—Doxorubicin—liver cancer	4.82e-05	0.000468	CcSEcCtD
Paclitaxel—Flushing—Epirubicin—liver cancer	4.82e-05	0.000467	CcSEcCtD
Paclitaxel—Cardiac disorder—Epirubicin—liver cancer	4.82e-05	0.000467	CcSEcCtD
Paclitaxel—Rhinitis—Doxorubicin—liver cancer	4.81e-05	0.000467	CcSEcCtD
Paclitaxel—Haemorrhage—Doxorubicin—liver cancer	4.8e-05	0.000465	CcSEcCtD
Paclitaxel—Hypoaesthesia—Doxorubicin—liver cancer	4.78e-05	0.000463	CcSEcCtD
Paclitaxel—Pharyngitis—Doxorubicin—liver cancer	4.76e-05	0.000462	CcSEcCtD
Paclitaxel—Urinary tract disorder—Doxorubicin—liver cancer	4.74e-05	0.00046	CcSEcCtD
Paclitaxel—Oedema peripheral—Doxorubicin—liver cancer	4.73e-05	0.000458	CcSEcCtD
Paclitaxel—Connective tissue disorder—Doxorubicin—liver cancer	4.72e-05	0.000457	CcSEcCtD
Paclitaxel—Angiopathy—Epirubicin—liver cancer	4.71e-05	0.000456	CcSEcCtD
Paclitaxel—Urethral disorder—Doxorubicin—liver cancer	4.71e-05	0.000456	CcSEcCtD
Paclitaxel—Immune system disorder—Epirubicin—liver cancer	4.69e-05	0.000454	CcSEcCtD
Paclitaxel—Mediastinal disorder—Epirubicin—liver cancer	4.68e-05	0.000453	CcSEcCtD
Paclitaxel—Chills—Epirubicin—liver cancer	4.66e-05	0.000451	CcSEcCtD
Paclitaxel—Arrhythmia—Epirubicin—liver cancer	4.63e-05	0.000449	CcSEcCtD
Paclitaxel—Visual impairment—Doxorubicin—liver cancer	4.63e-05	0.000448	CcSEcCtD
Paclitaxel—Alopecia—Epirubicin—liver cancer	4.58e-05	0.000444	CcSEcCtD
Paclitaxel—Mental disorder—Epirubicin—liver cancer	4.55e-05	0.000441	CcSEcCtD
Paclitaxel—Erythema multiforme—Doxorubicin—liver cancer	4.54e-05	0.00044	CcSEcCtD
Paclitaxel—Erythema—Epirubicin—liver cancer	4.52e-05	0.000438	CcSEcCtD
Paclitaxel—Malnutrition—Epirubicin—liver cancer	4.52e-05	0.000438	CcSEcCtD
Paclitaxel—Eye disorder—Doxorubicin—liver cancer	4.49e-05	0.000435	CcSEcCtD
Paclitaxel—Tinnitus—Doxorubicin—liver cancer	4.48e-05	0.000434	CcSEcCtD
Paclitaxel—Cardiac disorder—Doxorubicin—liver cancer	4.46e-05	0.000432	CcSEcCtD
Paclitaxel—Flushing—Doxorubicin—liver cancer	4.46e-05	0.000432	CcSEcCtD
Paclitaxel—Flatulence—Epirubicin—liver cancer	4.45e-05	0.000431	CcSEcCtD
Paclitaxel—Tension—Epirubicin—liver cancer	4.43e-05	0.00043	CcSEcCtD
Paclitaxel—Dysgeusia—Epirubicin—liver cancer	4.42e-05	0.000429	CcSEcCtD
Paclitaxel—Nervousness—Epirubicin—liver cancer	4.39e-05	0.000425	CcSEcCtD
Paclitaxel—Back pain—Epirubicin—liver cancer	4.37e-05	0.000424	CcSEcCtD
Paclitaxel—Angiopathy—Doxorubicin—liver cancer	4.36e-05	0.000422	CcSEcCtD
Paclitaxel—Muscle spasms—Epirubicin—liver cancer	4.34e-05	0.000421	CcSEcCtD
Paclitaxel—Immune system disorder—Doxorubicin—liver cancer	4.34e-05	0.00042	CcSEcCtD
Paclitaxel—Mediastinal disorder—Doxorubicin—liver cancer	4.33e-05	0.000419	CcSEcCtD
Paclitaxel—Chills—Doxorubicin—liver cancer	4.31e-05	0.000418	CcSEcCtD
Paclitaxel—Arrhythmia—Doxorubicin—liver cancer	4.29e-05	0.000416	CcSEcCtD
Paclitaxel—Vision blurred—Epirubicin—liver cancer	4.26e-05	0.000413	CcSEcCtD
Paclitaxel—Alopecia—Doxorubicin—liver cancer	4.24e-05	0.000411	CcSEcCtD
Paclitaxel—Mental disorder—Doxorubicin—liver cancer	4.21e-05	0.000408	CcSEcCtD
Paclitaxel—Ill-defined disorder—Epirubicin—liver cancer	4.19e-05	0.000406	CcSEcCtD
Paclitaxel—Malnutrition—Doxorubicin—liver cancer	4.18e-05	0.000405	CcSEcCtD
Paclitaxel—Erythema—Doxorubicin—liver cancer	4.18e-05	0.000405	CcSEcCtD
Paclitaxel—Anaemia—Epirubicin—liver cancer	4.17e-05	0.000405	CcSEcCtD
Paclitaxel—Agitation—Epirubicin—liver cancer	4.15e-05	0.000402	CcSEcCtD
Paclitaxel—Flatulence—Doxorubicin—liver cancer	4.12e-05	0.000399	CcSEcCtD
Paclitaxel—Tension—Doxorubicin—liver cancer	4.1e-05	0.000398	CcSEcCtD
Paclitaxel—Dysgeusia—Doxorubicin—liver cancer	4.09e-05	0.000397	CcSEcCtD
Paclitaxel—Malaise—Epirubicin—liver cancer	4.07e-05	0.000395	CcSEcCtD
Paclitaxel—Nervousness—Doxorubicin—liver cancer	4.06e-05	0.000393	CcSEcCtD
Paclitaxel—Vertigo—Epirubicin—liver cancer	4.06e-05	0.000393	CcSEcCtD
Paclitaxel—Syncope—Epirubicin—liver cancer	4.05e-05	0.000393	CcSEcCtD
Paclitaxel—Leukopenia—Epirubicin—liver cancer	4.04e-05	0.000392	CcSEcCtD
Paclitaxel—Back pain—Doxorubicin—liver cancer	4.04e-05	0.000392	CcSEcCtD
Paclitaxel—Muscle spasms—Doxorubicin—liver cancer	4.02e-05	0.000389	CcSEcCtD
Paclitaxel—Palpitations—Epirubicin—liver cancer	3.99e-05	0.000387	CcSEcCtD
Paclitaxel—Loss of consciousness—Epirubicin—liver cancer	3.97e-05	0.000385	CcSEcCtD
Paclitaxel—Cough—Epirubicin—liver cancer	3.94e-05	0.000382	CcSEcCtD
Paclitaxel—Vision blurred—Doxorubicin—liver cancer	3.94e-05	0.000382	CcSEcCtD
Paclitaxel—Convulsion—Epirubicin—liver cancer	3.91e-05	0.000379	CcSEcCtD
Paclitaxel—Hypertension—Epirubicin—liver cancer	3.9e-05	0.000378	CcSEcCtD
Paclitaxel—Ill-defined disorder—Doxorubicin—liver cancer	3.88e-05	0.000376	CcSEcCtD
Paclitaxel—Anaemia—Doxorubicin—liver cancer	3.86e-05	0.000374	CcSEcCtD
Paclitaxel—Chest pain—Epirubicin—liver cancer	3.85e-05	0.000373	CcSEcCtD
Paclitaxel—Myalgia—Epirubicin—liver cancer	3.85e-05	0.000373	CcSEcCtD
Paclitaxel—Arthralgia—Epirubicin—liver cancer	3.85e-05	0.000373	CcSEcCtD
Paclitaxel—Agitation—Doxorubicin—liver cancer	3.84e-05	0.000372	CcSEcCtD
Paclitaxel—Anxiety—Epirubicin—liver cancer	3.83e-05	0.000371	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	3.82e-05	0.00037	CcSEcCtD
Paclitaxel—Discomfort—Epirubicin—liver cancer	3.8e-05	0.000368	CcSEcCtD
Paclitaxel—Malaise—Doxorubicin—liver cancer	3.77e-05	0.000365	CcSEcCtD
Paclitaxel—Dry mouth—Epirubicin—liver cancer	3.76e-05	0.000365	CcSEcCtD
Paclitaxel—Vertigo—Doxorubicin—liver cancer	3.75e-05	0.000364	CcSEcCtD
Paclitaxel—Syncope—Doxorubicin—liver cancer	3.75e-05	0.000363	CcSEcCtD
Paclitaxel—Leukopenia—Doxorubicin—liver cancer	3.74e-05	0.000363	CcSEcCtD
Paclitaxel—Confusional state—Epirubicin—liver cancer	3.72e-05	0.00036	CcSEcCtD
Paclitaxel—Palpitations—Doxorubicin—liver cancer	3.69e-05	0.000358	CcSEcCtD
Paclitaxel—Anaphylactic shock—Epirubicin—liver cancer	3.69e-05	0.000357	CcSEcCtD
Paclitaxel—Oedema—Epirubicin—liver cancer	3.69e-05	0.000357	CcSEcCtD
Paclitaxel—Loss of consciousness—Doxorubicin—liver cancer	3.67e-05	0.000356	CcSEcCtD
Paclitaxel—Infection—Epirubicin—liver cancer	3.66e-05	0.000355	CcSEcCtD
Paclitaxel—Cough—Doxorubicin—liver cancer	3.65e-05	0.000354	CcSEcCtD
Paclitaxel—Shock—Epirubicin—liver cancer	3.63e-05	0.000352	CcSEcCtD
Paclitaxel—Convulsion—Doxorubicin—liver cancer	3.62e-05	0.000351	CcSEcCtD
Paclitaxel—Nervous system disorder—Epirubicin—liver cancer	3.61e-05	0.00035	CcSEcCtD
Paclitaxel—Thrombocytopenia—Epirubicin—liver cancer	3.61e-05	0.00035	CcSEcCtD
Paclitaxel—Hypertension—Doxorubicin—liver cancer	3.61e-05	0.00035	CcSEcCtD
Paclitaxel—Tachycardia—Epirubicin—liver cancer	3.6e-05	0.000349	CcSEcCtD
Paclitaxel—Skin disorder—Epirubicin—liver cancer	3.58e-05	0.000347	CcSEcCtD
Paclitaxel—Hyperhidrosis—Epirubicin—liver cancer	3.56e-05	0.000345	CcSEcCtD
Paclitaxel—Chest pain—Doxorubicin—liver cancer	3.56e-05	0.000345	CcSEcCtD
Paclitaxel—Arthralgia—Doxorubicin—liver cancer	3.56e-05	0.000345	CcSEcCtD
Paclitaxel—Myalgia—Doxorubicin—liver cancer	3.56e-05	0.000345	CcSEcCtD
Paclitaxel—Anxiety—Doxorubicin—liver cancer	3.55e-05	0.000344	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	3.53e-05	0.000343	CcSEcCtD
Paclitaxel—Discomfort—Doxorubicin—liver cancer	3.52e-05	0.000341	CcSEcCtD
Paclitaxel—Anorexia—Epirubicin—liver cancer	3.51e-05	0.000341	CcSEcCtD
Paclitaxel—Dry mouth—Doxorubicin—liver cancer	3.48e-05	0.000337	CcSEcCtD
Paclitaxel—Hypotension—Epirubicin—liver cancer	3.44e-05	0.000334	CcSEcCtD
Paclitaxel—Confusional state—Doxorubicin—liver cancer	3.44e-05	0.000333	CcSEcCtD
Paclitaxel—Anaphylactic shock—Doxorubicin—liver cancer	3.41e-05	0.000331	CcSEcCtD
Paclitaxel—Oedema—Doxorubicin—liver cancer	3.41e-05	0.000331	CcSEcCtD
Paclitaxel—Infection—Doxorubicin—liver cancer	3.39e-05	0.000328	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Epirubicin—liver cancer	3.36e-05	0.000326	CcSEcCtD
Paclitaxel—Shock—Doxorubicin—liver cancer	3.36e-05	0.000325	CcSEcCtD
Paclitaxel—Nervous system disorder—Doxorubicin—liver cancer	3.34e-05	0.000324	CcSEcCtD
Paclitaxel—Thrombocytopenia—Doxorubicin—liver cancer	3.34e-05	0.000324	CcSEcCtD
Paclitaxel—Insomnia—Epirubicin—liver cancer	3.33e-05	0.000323	CcSEcCtD
Paclitaxel—Tachycardia—Doxorubicin—liver cancer	3.33e-05	0.000323	CcSEcCtD
Paclitaxel—Skin disorder—Doxorubicin—liver cancer	3.31e-05	0.000321	CcSEcCtD
Paclitaxel—Paraesthesia—Epirubicin—liver cancer	3.31e-05	0.000321	CcSEcCtD
Paclitaxel—Hyperhidrosis—Doxorubicin—liver cancer	3.3e-05	0.00032	CcSEcCtD
Paclitaxel—Dyspnoea—Epirubicin—liver cancer	3.29e-05	0.000319	CcSEcCtD
Paclitaxel—Somnolence—Epirubicin—liver cancer	3.28e-05	0.000318	CcSEcCtD
Paclitaxel—Anorexia—Doxorubicin—liver cancer	3.25e-05	0.000315	CcSEcCtD
Paclitaxel—Dyspepsia—Epirubicin—liver cancer	3.24e-05	0.000315	CcSEcCtD
Paclitaxel—Decreased appetite—Epirubicin—liver cancer	3.2e-05	0.000311	CcSEcCtD
Paclitaxel—Hypotension—Doxorubicin—liver cancer	3.19e-05	0.000309	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Epirubicin—liver cancer	3.18e-05	0.000309	CcSEcCtD
Paclitaxel—Fatigue—Epirubicin—liver cancer	3.18e-05	0.000308	CcSEcCtD
Paclitaxel—Pain—Epirubicin—liver cancer	3.15e-05	0.000306	CcSEcCtD
Paclitaxel—Constipation—Epirubicin—liver cancer	3.15e-05	0.000306	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Doxorubicin—liver cancer	3.11e-05	0.000301	CcSEcCtD
Paclitaxel—Insomnia—Doxorubicin—liver cancer	3.08e-05	0.000299	CcSEcCtD
Paclitaxel—Paraesthesia—Doxorubicin—liver cancer	3.06e-05	0.000297	CcSEcCtD
Paclitaxel—Dyspnoea—Doxorubicin—liver cancer	3.04e-05	0.000295	CcSEcCtD
Paclitaxel—Feeling abnormal—Epirubicin—liver cancer	3.04e-05	0.000294	CcSEcCtD
Paclitaxel—Somnolence—Doxorubicin—liver cancer	3.03e-05	0.000294	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Epirubicin—liver cancer	3.01e-05	0.000292	CcSEcCtD
Paclitaxel—Dyspepsia—Doxorubicin—liver cancer	3e-05	0.000291	CcSEcCtD
Paclitaxel—Decreased appetite—Doxorubicin—liver cancer	2.96e-05	0.000287	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Doxorubicin—liver cancer	2.94e-05	0.000285	CcSEcCtD
Paclitaxel—Fatigue—Doxorubicin—liver cancer	2.94e-05	0.000285	CcSEcCtD
Paclitaxel—Urticaria—Epirubicin—liver cancer	2.93e-05	0.000284	CcSEcCtD
Paclitaxel—Constipation—Doxorubicin—liver cancer	2.92e-05	0.000283	CcSEcCtD
Paclitaxel—Pain—Doxorubicin—liver cancer	2.92e-05	0.000283	CcSEcCtD
Paclitaxel—Body temperature increased—Epirubicin—liver cancer	2.91e-05	0.000282	CcSEcCtD
Paclitaxel—Abdominal pain—Epirubicin—liver cancer	2.91e-05	0.000282	CcSEcCtD
Paclitaxel—Feeling abnormal—Doxorubicin—liver cancer	2.81e-05	0.000272	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Doxorubicin—liver cancer	2.79e-05	0.00027	CcSEcCtD
Paclitaxel—Hypersensitivity—Epirubicin—liver cancer	2.72e-05	0.000263	CcSEcCtD
Paclitaxel—Urticaria—Doxorubicin—liver cancer	2.71e-05	0.000263	CcSEcCtD
Paclitaxel—Abdominal pain—Doxorubicin—liver cancer	2.7e-05	0.000261	CcSEcCtD
Paclitaxel—Body temperature increased—Doxorubicin—liver cancer	2.7e-05	0.000261	CcSEcCtD
Paclitaxel—Asthenia—Epirubicin—liver cancer	2.64e-05	0.000256	CcSEcCtD
Paclitaxel—Pruritus—Epirubicin—liver cancer	2.61e-05	0.000253	CcSEcCtD
Paclitaxel—Diarrhoea—Epirubicin—liver cancer	2.52e-05	0.000244	CcSEcCtD
Paclitaxel—Hypersensitivity—Doxorubicin—liver cancer	2.51e-05	0.000244	CcSEcCtD
Paclitaxel—Asthenia—Doxorubicin—liver cancer	2.45e-05	0.000237	CcSEcCtD
Paclitaxel—Dizziness—Epirubicin—liver cancer	2.44e-05	0.000236	CcSEcCtD
Paclitaxel—Pruritus—Doxorubicin—liver cancer	2.41e-05	0.000234	CcSEcCtD
Paclitaxel—Vomiting—Epirubicin—liver cancer	2.34e-05	0.000227	CcSEcCtD
Paclitaxel—Diarrhoea—Doxorubicin—liver cancer	2.33e-05	0.000226	CcSEcCtD
Paclitaxel—Rash—Epirubicin—liver cancer	2.32e-05	0.000225	CcSEcCtD
Paclitaxel—Dermatitis—Epirubicin—liver cancer	2.32e-05	0.000225	CcSEcCtD
Paclitaxel—Headache—Epirubicin—liver cancer	2.31e-05	0.000224	CcSEcCtD
Paclitaxel—Dizziness—Doxorubicin—liver cancer	2.26e-05	0.000219	CcSEcCtD
Paclitaxel—Nausea—Epirubicin—liver cancer	2.19e-05	0.000212	CcSEcCtD
Paclitaxel—Vomiting—Doxorubicin—liver cancer	2.17e-05	0.00021	CcSEcCtD
Paclitaxel—Rash—Doxorubicin—liver cancer	2.15e-05	0.000208	CcSEcCtD
Paclitaxel—Dermatitis—Doxorubicin—liver cancer	2.15e-05	0.000208	CcSEcCtD
Paclitaxel—Headache—Doxorubicin—liver cancer	2.14e-05	0.000207	CcSEcCtD
Paclitaxel—Nausea—Doxorubicin—liver cancer	2.03e-05	0.000196	CcSEcCtD
Paclitaxel—SLCO1B3—Metabolism—PPARG—liver cancer	3.44e-06	4.25e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CRABP1—liver cancer	3.43e-06	4.24e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTA2—liver cancer	3.43e-06	4.23e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GSTM1—liver cancer	3.41e-06	4.21e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—AKT1—liver cancer	3.4e-06	4.21e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GSTM1—liver cancer	3.39e-06	4.19e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MAPK8—liver cancer	3.36e-06	4.16e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CG—liver cancer	3.35e-06	4.15e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTA1—liver cancer	3.3e-06	4.09e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	3.3e-06	4.08e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTA4—liver cancer	3.28e-06	4.06e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GSTM1—liver cancer	3.28e-06	4.06e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	3.28e-06	4.05e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NAT2—liver cancer	3.27e-06	4.04e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GSTP1—liver cancer	3.25e-06	4.02e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PPARG—liver cancer	3.24e-06	4e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CYP1A1—liver cancer	3.23e-06	3.99e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GSTP1—liver cancer	3.22e-06	3.98e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP1A1—liver cancer	3.22e-06	3.98e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.21e-06	3.97e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—HMOX1—liver cancer	3.2e-06	3.96e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTA2—liver cancer	3.2e-06	3.96e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—HMOX1—liver cancer	3.18e-06	3.93e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALDOB—liver cancer	3.13e-06	3.87e-05	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—AKT1—liver cancer	3.13e-06	3.87e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CD—liver cancer	3.13e-06	3.87e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CYP1A1—liver cancer	3.11e-06	3.85e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ALB—liver cancer	3.09e-06	3.82e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.09e-06	3.82e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTA1—liver cancer	3.09e-06	3.82e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PSMA4—liver cancer	3.09e-06	3.81e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PSMD10—liver cancer	3.09e-06	3.81e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—STAT3—liver cancer	3.08e-06	3.8e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NAT2—liver cancer	3.05e-06	3.77e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—MTHFR—liver cancer	3.01e-06	3.72e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	3.01e-06	3.72e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—APC—liver cancer	3.01e-06	3.72e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GOT2—liver cancer	3e-06	3.71e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—HPGDS—liver cancer	3e-06	3.71e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—MTHFR—liver cancer	3e-06	3.71e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CRABP1—liver cancer	2.99e-06	3.69e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.99e-06	3.69e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GSTM1—liver cancer	2.99e-06	3.69e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.98e-06	3.69e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GSTM1—liver cancer	2.96e-06	3.66e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PPARA—liver cancer	2.95e-06	3.65e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CD—liver cancer	2.95e-06	3.64e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PPARA—liver cancer	2.94e-06	3.64e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.94e-06	3.63e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALDOB—liver cancer	2.93e-06	3.62e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.91e-06	3.6e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ALB—liver cancer	2.91e-06	3.6e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—MTHFR—liver cancer	2.9e-06	3.58e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PPARA—liver cancer	2.85e-06	3.52e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP1A1—liver cancer	2.83e-06	3.5e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—BRAF—liver cancer	2.83e-06	3.49e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP2E1—liver cancer	2.82e-06	3.49e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP1A1—liver cancer	2.81e-06	3.47e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CRABP1—liver cancer	2.79e-06	3.45e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CB—liver cancer	2.73e-06	3.37e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.72e-06	3.36e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.68e-06	3.31e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PSMA4—liver cancer	2.67e-06	3.3e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PSMD10—liver cancer	2.67e-06	3.3e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.65e-06	3.28e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CD—liver cancer	2.64e-06	3.27e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.64e-06	3.27e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KRAS—liver cancer	2.64e-06	3.26e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYCS—liver cancer	2.64e-06	3.26e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—MTHFR—liver cancer	2.64e-06	3.26e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SERPINE1—liver cancer	2.62e-06	3.23e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—MTHFR—liver cancer	2.62e-06	3.23e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—HPGDS—liver cancer	2.61e-06	3.23e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GOT2—liver cancer	2.6e-06	3.21e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GGT1—liver cancer	2.59e-06	3.2e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GOT1—liver cancer	2.59e-06	3.2e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PPARA—liver cancer	2.59e-06	3.2e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CB—liver cancer	2.57e-06	3.18e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PPARA—liver cancer	2.57e-06	3.17e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.56e-06	3.16e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CG—liver cancer	2.53e-06	3.13e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CG—liver cancer	2.52e-06	3.11e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.51e-06	3.11e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CPT1B—liver cancer	2.5e-06	3.09e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GLUL—liver cancer	2.5e-06	3.09e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.46e-06	3.04e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP2E1—liver cancer	2.44e-06	3.02e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PPARG—liver cancer	2.44e-06	3.02e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HPGDS—liver cancer	2.44e-06	3.02e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CG—liver cancer	2.44e-06	3.01e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PPARG—liver cancer	2.43e-06	3.01e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.43e-06	3e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PIK3CA—liver cancer	2.43e-06	3e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NR1H4—liver cancer	2.41e-06	2.98e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTA3—liver cancer	2.37e-06	2.93e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.37e-06	2.93e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—RAF1—liver cancer	2.36e-06	2.92e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PPARG—liver cancer	2.35e-06	2.91e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PSMA4—liver cancer	2.33e-06	2.88e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PSMD10—liver cancer	2.33e-06	2.88e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTP1—liver cancer	2.33e-06	2.88e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CB—liver cancer	2.3e-06	2.85e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MTOR—liver cancer	2.3e-06	2.85e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—HMOX1—liver cancer	2.3e-06	2.84e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYCS—liver cancer	2.29e-06	2.83e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GOT2—liver cancer	2.27e-06	2.8e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HRAS—liver cancer	2.24e-06	2.77e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GOT1—liver cancer	2.24e-06	2.77e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GGT1—liver cancer	2.24e-06	2.77e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CD—liver cancer	2.22e-06	2.75e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.22e-06	2.74e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CG—liver cancer	2.22e-06	2.74e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CD—liver cancer	2.21e-06	2.74e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.21e-06	2.73e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CG—liver cancer	2.2e-06	2.72e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ALB—liver cancer	2.2e-06	2.71e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ALB—liver cancer	2.19e-06	2.7e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.18e-06	2.7e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PSMA4—liver cancer	2.18e-06	2.69e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PSMD10—liver cancer	2.18e-06	2.69e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTA4—liver cancer	2.17e-06	2.68e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1B—liver cancer	2.16e-06	2.67e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—liver cancer	2.15e-06	2.66e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CD—liver cancer	2.14e-06	2.65e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PPARG—liver cancer	2.14e-06	2.64e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTM1—liver cancer	2.14e-06	2.64e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP2E1—liver cancer	2.13e-06	2.63e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PPARG—liver cancer	2.12e-06	2.62e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GOT2—liver cancer	2.12e-06	2.62e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ALB—liver cancer	2.11e-06	2.61e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTA2—liver cancer	2.11e-06	2.61e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CTNNB1—liver cancer	2.04e-06	2.53e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTA1—liver cancer	2.04e-06	2.52e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP1A1—liver cancer	2.03e-06	2.51e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTP1—liver cancer	2.02e-06	2.49e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NAT2—liver cancer	2.01e-06	2.49e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.01e-06	2.48e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1A—liver cancer	2e-06	2.47e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYCS—liver cancer	1.99e-06	2.46e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP2E1—liver cancer	1.99e-06	2.46e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—HMOX1—liver cancer	1.99e-06	2.46e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AKT1—liver cancer	1.98e-06	2.45e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GGT1—liver cancer	1.96e-06	2.42e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GOT1—liver cancer	1.96e-06	2.42e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CD—liver cancer	1.95e-06	2.41e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CB—liver cancer	1.94e-06	2.4e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CD—liver cancer	1.93e-06	2.39e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CB—liver cancer	1.93e-06	2.39e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALDOB—liver cancer	1.93e-06	2.39e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.93e-06	2.38e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ALB—liver cancer	1.92e-06	2.38e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ALB—liver cancer	1.91e-06	2.36e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—MTHFR—liver cancer	1.89e-06	2.34e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CB—liver cancer	1.87e-06	2.31e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYCS—liver cancer	1.86e-06	2.3e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PPARA—liver cancer	1.85e-06	2.29e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTM1—liver cancer	1.85e-06	2.29e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CRABP1—liver cancer	1.84e-06	2.28e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GGT1—liver cancer	1.83e-06	2.26e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GOT1—liver cancer	1.83e-06	2.26e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—STAT3—liver cancer	1.78e-06	2.2e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTP1—liver cancer	1.76e-06	2.17e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP1A1—liver cancer	1.76e-06	2.17e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—HMOX1—liver cancer	1.73e-06	2.14e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CB—liver cancer	1.7e-06	2.1e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CB—liver cancer	1.68e-06	2.08e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CA—liver cancer	1.66e-06	2.06e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—liver cancer	1.66e-06	2.05e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TGFB1—liver cancer	1.65e-06	2.04e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTP1—liver cancer	1.64e-06	2.03e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—MTHFR—liver cancer	1.64e-06	2.02e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HMOX1—liver cancer	1.62e-06	2e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTM1—liver cancer	1.61e-06	2e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HPGDS—liver cancer	1.61e-06	1.99e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PPARA—liver cancer	1.61e-06	1.99e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CG—liver cancer	1.59e-06	1.96e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CA—liver cancer	1.57e-06	1.94e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PPARG—liver cancer	1.53e-06	1.89e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP1A1—liver cancer	1.53e-06	1.89e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—liver cancer	1.53e-06	1.89e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTM1—liver cancer	1.51e-06	1.86e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.44e-06	1.78e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PSMA4—liver cancer	1.43e-06	1.77e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PSMD10—liver cancer	1.43e-06	1.77e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP1A1—liver cancer	1.43e-06	1.77e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—MTHFR—liver cancer	1.43e-06	1.76e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CA—liver cancer	1.41e-06	1.74e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PPARA—liver cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CD—liver cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GOT2—liver cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ALB—liver cancer	1.38e-06	1.7e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CG—liver cancer	1.38e-06	1.7e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AKT1—liver cancer	1.36e-06	1.68e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—MTHFR—liver cancer	1.33e-06	1.65e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PPARG—liver cancer	1.33e-06	1.64e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP2E1—liver cancer	1.31e-06	1.62e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PPARA—liver cancer	1.31e-06	1.62e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HRAS—liver cancer	1.3e-06	1.61e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AKT1—liver cancer	1.28e-06	1.58e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—liver cancer	1.24e-06	1.54e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYCS—liver cancer	1.23e-06	1.52e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CB—liver cancer	1.22e-06	1.5e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CD—liver cancer	1.21e-06	1.49e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GGT1—liver cancer	1.2e-06	1.49e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GOT1—liver cancer	1.2e-06	1.49e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CG—liver cancer	1.2e-06	1.48e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ALB—liver cancer	1.19e-06	1.48e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CA—liver cancer	1.18e-06	1.46e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CA—liver cancer	1.18e-06	1.45e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.17e-06	1.45e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PPARG—liver cancer	1.16e-06	1.43e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT1—liver cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CA—liver cancer	1.14e-06	1.41e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CG—liver cancer	1.12e-06	1.38e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTP1—liver cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PPARG—liver cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HMOX1—liver cancer	1.07e-06	1.32e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CB—liver cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CD—liver cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALB—liver cancer	1.04e-06	1.29e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CA—liver cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CA—liver cancer	1.03e-06	1.27e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTM1—liver cancer	9.94e-07	1.23e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CD—liver cancer	9.84e-07	1.22e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALB—liver cancer	9.72e-07	1.2e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKT1—liver cancer	9.65e-07	1.19e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKT1—liver cancer	9.61e-07	1.19e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP1A1—liver cancer	9.43e-07	1.17e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKT1—liver cancer	9.3e-07	1.15e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CB—liver cancer	9.18e-07	1.14e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MTHFR—liver cancer	8.79e-07	1.09e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPARA—liver cancer	8.62e-07	1.07e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CB—liver cancer	8.58e-07	1.06e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKT1—liver cancer	8.46e-07	1.05e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKT1—liver cancer	8.38e-07	1.04e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CA—liver cancer	7.42e-07	9.17e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CG—liver cancer	7.38e-07	9.13e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPARG—liver cancer	7.13e-07	8.81e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CD—liver cancer	6.49e-07	8.02e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CA—liver cancer	6.43e-07	7.94e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALB—liver cancer	6.41e-07	7.92e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKT1—liver cancer	6.06e-07	7.49e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CB—liver cancer	5.66e-07	6.99e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CA—liver cancer	5.6e-07	6.92e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKT1—liver cancer	5.25e-07	6.49e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CA—liver cancer	5.23e-07	6.46e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKT1—liver cancer	4.57e-07	5.65e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKT1—liver cancer	4.27e-07	5.28e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CA—liver cancer	3.45e-07	4.26e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKT1—liver cancer	2.82e-07	3.48e-06	CbGpPWpGaD
